JULIAN ADAMS
CIK 1230486 · Chief Executive Officer · last filed 2025-05-20
JULIAN ADAMS is a Chief Executive Officer who has filed 24 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ELTX, was dated May 20, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
24
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELTX | Director | — | $14.85 | — | $0 | 3 | 2025-05-20 |
| Gamida Cell Ltd. (GMDA) Delisted | Chief Executive Officer | 423,750 | $0.03 | $13.9K | $0 | 5 | 2024-02-02 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 3 | 2018-01-29 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | President of R&D | 322,095 | $0.04 | $14.4K | $0 | 13 | 2016-11-02 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-20 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2024-11-25 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2023-12-29 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2023-10-20 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +28,300 | $0 | EDGAR |
| 2023-02-10 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +28,300 | $0 | EDGAR |
| 2022-11-22 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2022-08-10 | Gamida Cell Ltd. (GMDA) Delisted | Grant (A) | +117,300 | $0 | EDGAR |
| 2018-01-29 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-30 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |